SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-089837
Filing Date
2024-08-14
Accepted
2024-08-14 21:46:33
Documents
2
Period of Report
2024-08-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2421771-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2421771-1_3seq1.xml 3 1557
2 EXHIBIT 24 tm2421771d1_ex24.htm EX-24 6609
  Complete submission text file 0001104659-24-089837.txt   9924
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address
Ramdeen Timothy R. (Reporting) CIK: 0001962363 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37853 | Film No.: 241210438